维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="ILLEI G G"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythe- matosus 显示文摘	Valencia X Yarboro C Illei G	2007	J Immunol2007，178，4：	1
2	Distinct T Cell/Renal Tubular Epithelial Cell Interactions Define Differential Chemokine Production:Implications for Tubulointerstitial Injury in Chronic Glomerulonephritis显示文摘	Kuroiwa T Schlimgen R Illei G G	2000	Immunol2000，164，：	1
3	Tocil- izumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study 显示文摘	ILLEI G G SHIROTA Y YARBORO C H	2010	Arthritis Rheum2010，62，2：	1
4	Deficient CD4+CD25higb T regulatory cell function in patients with active systemic lupus erythematosus显示文摘	Valencia X Yarboro C Illei G		0，，04：	1
5	MicroRNAs in Sjogren' s syndrome as a proto- typic autoimmune disease显示文摘	Alevizos I Illei G G	2010	Autoimmun Rev2010，9，：	1
6	Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides 显示文摘	Zeuner RA Klinman DM Illei G	2003	Rheumatology (Oxford)2003，42，4：	1
7	Biomarkers in systemic lupus erythematosus显示文摘	Illei G G Lipsky P E	2004	Curr Rheumatol Rep2004，6，：	1
8	Micrornas as biomarkers in rheumatic diseases显示文摘	ALEVIZOS I ILLEI G G	2010	Nat Rev Rheumatol2010，6，：	1
9	Pathogenesis of Sjgren′s syndrome显示文摘	NIKOLOV N P ILLEI G G	2009	Curr Opin Rheumatol2009，21，5：	1
10	MicroRNAs as biomarkers in rheumatic diseases显示文摘	Alevizos I Illei G G	2010	Nat Rev Rheumatol2010，6，7：	1
11	Rationale for interleukin-6 blockade in systemic lupus erythematosus显示文摘	Tackey E Lipsky P E Illei G G	2004	Lupus2004，13，5：	1
12	Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus显示文摘	Valencia X Yarboro C Illei G	2007	J Immunol2007，178，4：	1
13	Liver from bone marrow in humans显示文摘	Theise ND Nimmakayalu M Gardner R Illei PB Morgan G Teperman L Henegariu O Krause DS	2000	Hepatology2000，32，1：	1
14	Cyclophosphamide for the Treatment of Systemic Lupus Erythematosus显示文摘	Takada K Illei G G Boumpas D T	2001	Lupus2001，10，3：	1
15	Rationale for interleukin-6 blockade in systemic lupus erythematosus显示文摘	Tackey E Lipsky P E Illei G G	2004	Lupus2004，13，5：	1
16	Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides显示文摘	ZEUNER R A KLINMAN D M ILLEI G	2003	Rheumatology(Oxford)2003，42，4：	1
17	The Percentage of FoxP3+Helios+ Treg Cells Correlates Positively With Disease Activity in Systemic Lupus Erythematosus 显示文摘	Golding A Hasni S Illei G	2013	Arthritis Rheum2013，65，11：	1
18	Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus显示文摘	Valencia X Yarboro C Illei G		0，，04：	1
19	Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production:implications for tubulointerstitial injury in chronic glomerulonephritides显示文摘	Kuroiwa T Schlimgen R Illei G G	2000	J Immunol2000，164，6：	1
20	Biomarkers in systemic lupus erythematosus:(Ⅱ)markers of disease activity显示文摘	Illei G G Tackey E Lapteva L	2004	Arthritis & Rheumatism2004，50，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示